Dr. Reddy's Laboratories
137 hedge funds and large institutions have $655M invested in Dr. Reddy's Laboratories in 2018 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 33 reducing their positions, and 12 closing their positions.
142% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 12
52% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 33
13% more funds holding
Funds holding: 121 → 137 (+16)
4.39% less ownership
Funds ownership: 65.65% → 61.26% (-4.4%)
8% less capital invested
Capital invested by funds: $711M → $655M (-$56.7M)
56% less call options, than puts
Call options by funds: $406K | Put options by funds: $929K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$17.6M |
| 2 |
MWNA
Marshall Wace North America
New York
|
+$16.3M |
| 3 |
D.E. Shaw & Co
New York
|
+$15.1M |
| 4 |
Millennium Management
New York
|
+$9.14M |
| 5 |
Two Sigma Investments
New York
|
+$8.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
-$165M |
| 2 |
SAM
Senzar Asset Management
New York
|
-$9.65M |
| 3 |
H
Hexavest
Montreal,
Quebec, Canada
|
-$4.34M |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
-$3.98M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.24M |
RDY Hedge Fund Activity: Q2 2018 in Review
137 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2018, worth a combined $655M — down 8% from $711M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new RDY positions and 12 closed out — a net gain of 17 holders — while 50 added to existing stakes and 33 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $17.6M. The largest seller was Fisher Asset Management, exiting entirely with an estimated $165M sold.
- 137 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2018, up from 121 in Q1 2018.
- Funds reported $655M of Dr. Reddy's Laboratories stock for Q2 2018, down 8% quarter-over-quarter.
- 29 funds opened new Dr. Reddy's Laboratories positions in Q2 2018 and 12 closed out, a net change of +17 holders.
- The largest Dr. Reddy's Laboratories buyer in Q2 2018 was Renaissance Technologies, an estimated $17.6M added.
- The largest Dr. Reddy's Laboratories seller in Q2 2018 was Fisher Asset Management, an estimated $165M sold.
Based on aggregated 13F filings for Q2 2018.